BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.
To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.
To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.
A handful of drugs prescribed to injured workers in California make up a “disproportionate” share of workers comp prescription payments, according to research released Monday by the California Workers’ Compensation Institute.
The so-called “low-volume/high-cost” drugs include dermatological drugs, opioids and antidepressants and have become cost drivers, the researchers found.
The report says topical dermatologicals, the fourth-most prevalent drug category in 2021, accounted for 9.3% of workers comp prescriptions but 17.3% of all prescription drug payments. That was up from 12.8% of payments in 2012, which the study ascribes to increased use and the emergence of high-priced topical analgesics.
Opioids’ share of overall prescriptions continued to drop, with the total drug spend falling to 5.8%, down from 26.7% a decade earlier. During the same period, the mix of opioids used to treat injured workers shifted, and the study noted three low-volume/high-priced opioids that have become cost drivers within their group, including oxycodone, a popular and strong pain medication.
The top four antidepressants dispensed to injured workers in 2021 represented nearly 2/3 of the antidepressants used, but all four were relatively low-cost drugs, accounting for only 42.5% of the payments in that drug group.